de Koning H - Search Results

1

Baseline Characteristics and Mortality Outcomes of Control Group Participants and Eligible Non-Responders in the NELSON Lung Cancer Screening Study.

Yousaf-Khan U, Horeweg N, van der Aalst C, Ten Haaf K, Oudkerk M, de Koning H. Yousaf-Khan U, et al. Among authors: de koning h. J Thorac Oncol. 2015 May;10(5):747-753. doi: 10.1097/JTO.0000000000000488. J Thorac Oncol. 2015. PMID: 25664626 Free article. Clinical Trial.

2

Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors.

de Koning HJ, van Ineveld BM, van Oortmarssen GJ, de Haes JC, Collette HJ, Hendriks JH, van der Maas PJ. de Koning HJ, et al. Among authors: de haes jc. Int J Cancer. 1991 Oct 21;49(4):531-7. doi: 10.1002/ijc.2910490410. Int J Cancer. 1991. PMID: 1917154

3

The impact of a breast cancer screening programme on quality-adjusted life-years.

de Haes JC, de Koning HJ, van Oortmarssen GJ, van Agt HM, de Bruyn AE, van Der Maas PJ. de Haes JC, et al. Among authors: de bruyn ae, de koning hj. Int J Cancer. 1991 Oct 21;49(4):538-44. doi: 10.1002/ijc.2910490411. Int J Cancer. 1991. PMID: 1917155

4

A model for breast cancer screening.

van Oortmarssen GJ, Habbema JD, van der Maas PJ, de Koning HJ, Collette HJ, Verbeek AL, Geerts AT, Lubbe KT. van Oortmarssen GJ, et al. Among authors: de koning hj. Cancer. 1990 Oct 1;66(7):1601-12. doi: 10.1002/1097-0142(19901001)66:7<1601::aid-cncr2820660727>3.0.co;2-o. Cancer. 1990. PMID: 2119877

5

Breast cancer screening: its impact on clinical medicine.

de Koning HJ, van Oortmarssen GJ, van Ineveld BM, van der Maas PJ. de Koning HJ, et al. Br J Cancer. 1990 Feb;61(2):292-7. doi: 10.1038/bjc.1990.55. Br J Cancer. 1990. PMID: 2310681 Free PMC article.

6

The cost-effectiveness of breast cancer screening.

van der Maas PJ, de Koning HJ, van Ineveld BM, van Oortmarssen GJ, Habbema JD, Lubbe KT, Geerts AT, Collette HJ, Verbeek AL, Hendriks JH, et al. van der Maas PJ, et al. Among authors: de koning hj. Int J Cancer. 1989 Jun 15;43(6):1055-60. doi: 10.1002/ijc.2910430617. Int J Cancer. 1989. PMID: 2499553

7

Nation-wide breast cancer screening in The Netherlands: support for breast-cancer mortality reduction. National Evaluation Team for Breast Cancer Screening (NETB).

De Koning HJ, Fracheboud J, Boer R, Verbeek AL, Collette HJ, Hendriks JH, van Ineveld BM, de Bruyn AE, van der Maas PJ. De Koning HJ, et al. Among authors: de bruyn ae. Int J Cancer. 1995 Mar 16;60(6):777-80. doi: 10.1002/ijc.2910600608. Int J Cancer. 1995. PMID: 7896444

8

Prediction of the effects and costs of breast-cancer screening in Germany.

Beemsterboer PM, de Koning HJ, Warmerdam PG, Boer R, Swart E, Dierks ML, Robra BP. Beemsterboer PM, et al. Among authors: de koning hj. Int J Cancer. 1994 Sep 1;58(5):623-8. doi: 10.1002/ijc.2910580502. Int J Cancer. 1994. PMID: 8077045

9

European randomized study of screening for prostate cancer--the Rotterdam pilot studies.

Shröder FH, Damhuis RA, Kirkels WJ, De Koning HJ, Kranse R, Nus HG, Blijenberg BG. Shröder FH, et al. Among authors: de koning hj. Int J Cancer. 1996 Jan 17;65(2):145-51. doi: 10.1002/(SICI)1097-0215(19960117)65:2<145::AID-IJC4>3.0.CO;2-Z. Int J Cancer. 1996. PMID: 8567109 Clinical Trial.

10

European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam pilot studies.

Schröder FH, Denis LJ, Kirkels W, de Koning HJ, Standaert B. Schröder FH, et al. Among authors: de koning hj. Cancer. 1995 Jul 1;76(1):129-34. doi: 10.1002/1097-0142(19950701)76:1<129::aid-cncr2820760120>3.0.co;2-1. Cancer. 1995. PMID: 8630864 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

788 results

Search Page

Filters